State health officials say Wisconsin has received its first allocation oral antiviral COVID-19 treatments.  The Department of Health Services has received the first, extremely limited supply of molnupiravir and Paxlovid to treat patients diagnosed with mild to moderate COVID-19.  Health care providers are encouraged to prioritize prescribing the new therapeutics to patients at greatest risk of serious illness or hospitalization from coronavirus.  D-H-S Secretary-designee Karen Timberlake says it’s important to remember these pills are not a substitution for protecting yourself by getting vaccinated and wearing a mask in public places.